Gainesville, FL, United States of America

Ferenc Soti

This inventor holds 7 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: University of Florida Research Foundation Inc., Duke University, University of Pennsylvania. Active years: 2006-2016.

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 28.6

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)

Company Filing History:

7 out of 3,046

University of Florida Research Foundation Inc.

University of Pennsylvania

patents

where one patent can have more than one assignee

Years Active: 2006-2016

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9440948 - Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use (2016-09-13),

2. 9233109 - Compositions, methods of use, and methods of treatment (2016-01-12),

3. 9150558 - Nicotine receptor targeted compounds and compositions (2015-10-06),

4. 8592458 - Alpha7 nicotinic receptor selective ligands (2013-11-26),

5. 8093269 - Alpha 7 nicotinic receptor selective ligands (2012-01-10),

6. 7307171 - Materials and methods for inhibiting fouling of surfaces exposed to aquatic environments (2007-12-11),

7. 7087106 - Materials and methods for inhibiting fouling of surfaces exposed to aquatic environments (2006-08-08),

Title: Ferenc Soti: Innovator in Nicotine Compounds

Introduction

Ferenc Soti is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of nicotine compounds and their applications. With a total of 7 patents, Soti's work focuses on innovative methods and compositions that address nicotine dependence and related disorders.

Latest Patents

Soti's latest patents include a range of nicotine compounds and analogs, as well as synthetic methods for creating these compounds. His inventions encompass 2'substituted nicotine compounds, azetidine compounds, and ether-linked nicotine compounds. These patents also detail methods for synthesizing these compounds and their use in treating conditions such as nicotine dependence and neuropsychiatric disorders. The embodiments of his disclosures provide valuable insights into selectively stimulating alpha7 nAChR and/or alpha4beta2 receptors.

Career Highlights

Throughout his career, Ferenc Soti has worked with esteemed institutions such as the University of Florida Research Foundation Inc and Duke University. His research has significantly advanced the understanding of nicotine's effects and potential treatments for those struggling with dependence.

Collaborations

Soti has collaborated with notable colleagues, including William Reade Kem and Hong Xing, contributing to the advancement of research in his field.

Conclusion

Ferenc Soti's innovative work in nicotine compounds and their applications has made a lasting impact on the field. His patents and research continue to pave the way for new treatments and methods in addressing nicotine dependence and related disorders.